Only organisations may obtain authorisation to import or export embryonic stem cells for research purposes:
1° Holders of the authorisation provided for in Article L. 2151-5 ;
2° Having made the declaration provided for in Article L. 2151-6, without the Director General of the Agence de la biomédecine having objected to the implementation of the protocol, or the declaration provided for in Article L. 2151-9.